首页> 外文期刊>Nature >Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells
【24h】

Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells

机译:多能造血干细胞的等级相关谱系限制命运

获取原文
获取原文并翻译 | 示例
           

摘要

Rare multipotent haematopoietic stem cells (HSCs) in adult bone marrow with extensive self-renewal potential can efficiently replenish all myeloid and lymphoid blood cells(1), securing long-term multilineage reconstitution after physiological and clinical challenges such as chemotherapy and haematopoietic transplantations(2-4). HSC transplantation remains the only curative treatment for many haematological malignancies, but inefficient blood-lineage replenishment remains a major cause of morbidity and mortality(5,6). Single-cell transplantation has uncovered considerable heterogeneity among reconstituting HSCs7-11, a finding that is supported by studies of unperturbed haematopoiesis(2-4,12) and may reflect different propensities for lineage-fate decisions by distinct myeloid-, lymphoid-and platelet-biased HSCs7-10,13. Other studies suggested that such lineage bias might reflect generation of unipotent or oligopotent self-renewing progenitors within the phenotypic HSC compartment, and implicated uncoupling of the defining HSC properties of self-renewal and multipotency(11,14). Here we use highly sensitive tracking of progenitors and mature cells of the megakaryocyte/platelet, erythroid, myeloid and B and T cell lineages, produced from singly transplanted HSCs, to reveal a highly organized, predictable and stable framework for lineage-restricted fates of long-term self-renewing HSCs. Most notably, a distinct class of HSCs adopts a fate towards effective and stable replenishment of a megakaryocyte/platelet-lineage tree but not of other blood cell lineages, despite sustained multipotency. No HSCs contribute exclusively to any other single blood-cell lineage. Single multipotent HSCs can also fully restrict towards simultaneous replenishment of megakaryocyte, erythroid and myeloid lineages without executing their sustained lymphoid lineage potential. Genetic lineage-tracing analysis also provides evidence for an important role of plateletbiased HSCs in unperturbed adult haematopoiesis. These findings uncover a limited repertoire of distinct HSC subsets, defined by a predictable and hierarchical propensity to adopt a fate towards replenishment of a restricted set of blood lineages, before loss of self-renewal and multipotency.
机译:成年骨髓中具有广泛自我更新潜力的稀有多能造血干细胞(HSC)可以有效补充所有髓样和淋巴血细胞(1),确保在进行化学和造血移植等生理和临床挑战后能够长期进行多谱系重建(2)。 -4)。 HSC移植仍然是许多血液系统恶性肿瘤的唯一治疗方法,但是血统补充不足仍然是发病率和死亡率的主要原因(5,6)。单细胞移植在重组HSCs7-11中发现了相当大的异质性,这一发现得到了无干扰的造血功能的研究支持(2-4,12),并且可能反映了不同的髓样,淋巴样和血小板对血统命运决定的不同倾向。偏向HSCs 7-10,13。其他研究表明,这种谱系偏倚可能反映了表型HSC区室中单能或寡能的自我更新祖细胞的产生,并暗示了自我更新和专能的定义HSC特性的脱钩(11,14)。在这里,我们使用由单个移植的HSC产生的巨核细胞/血小板,红系,髓样以及B和T细胞谱系的祖细胞和成熟细胞的高灵敏度跟踪,揭示了高度组织,可预测和稳定的框架,用于限制长谱系的命运定期自我更新HSC。最显着的是,尽管持续的多能性,不同类别的HSC对命运的目的是有效稳定地补充巨核细胞/血小板谱系树,而不是其他血细胞谱系。没有HSC专门贡献于任何其他单个血细胞谱系。单个多能HSC也可以完全限制同时补充巨核细胞,红系和髓系,而不执行其持续的淋巴系潜能。遗传谱系追踪分析也提供了证据,证明血小板偏置的HSC在未受干扰的成年造血功能中的重要作用。这些发现揭示了不同的HSC亚群的有限组成,其由可预测的和分层的倾向决定,该倾向倾向于在丧失自我更新和多能性之前采取命运补充有限的血统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号